Complete monosomy 13, the total absence of one copy of chromosome 13, has never been documented in a liveborn infant. Systematic reviews of autosomal monosomy survivors found no reported cases for any of the larger chromosomes, including chromosome 13, likely because losing an entire chromosome that gene-dense is incompatible with embryonic development. What clinicians and families actually encounter is partial monosomy 13, more commonly called 13q deletion syndrome, in which a segment of chromosome 13’s long arm is missing. The size and location of that missing segment largely dictate how severely a child is affected, making this one of the more variable chromosome conditions in terms of outcome.
Why Full Monosomy 13 Does Not Survive
Human cells normally carry two copies of each autosome. Losing an entire autosome means losing thousands of genes at once, and for most chromosomes the resulting imbalance is so disruptive that the embryo fails very early in development. A systematic literature review looking specifically for autosomal monosomy survivors found zero reports of live births with monosomy for chromosomes 1 through 13, or for chromosomes 17 and 19, the autosomes with the highest gene density.1PubMed. Should embryos with autosomal monosomy by preimplantation genetic testing for aneuploidy be transferred?: Implications for embryo selection from a systematic literature review of autosomal monosomy survivors Comparative work in mice confirms this general principle: deletions within the region that corresponds to human chromosome 13q22 cause embryonic arrest around the eighth day of development due to problems with basic tissue formation.2PubMed. Candidate genes required for embryonic development: a comparative analysis of distal mouse chromosome 14 and human chromosome 13q22 In short, the loss is too massive for the embryo to compensate. Most complete monosomy 13 conceptions likely miscarry so early that they are never recognized as pregnancies.
Partial Monosomy 13 and the 13q Deletion Spectrum
When people refer to “monosomy 13” in a clinical setting, they almost always mean a partial deletion of the long arm (q arm) of chromosome 13. These deletions range from tiny losses of a few genes to large missing stretches spanning tens of millions of DNA base pairs. The deleted material can sit near the centromere (proximal deletions), in the middle of the arm, or out toward the tip (distal deletions). Some individuals carry ring chromosome 13, where both ends of the chromosome break and rejoin into a circle, losing material from the tips. Others have unbalanced translocations, in which a rearrangement between chromosome 13 and another chromosome results in a net loss of 13q material along with, sometimes, a gain of material from the other chromosome.3Fetal Diagnosis and Therapy. Prenatal detection of a subtle unbalanced chromosome rearrangement by karyotyping, FISH and array comparative genomic hybridization
Because the clinical picture depends so heavily on which genes are missing, specialists have worked for decades to build a phenotype map of chromosome 13q. One large mapping study using high-resolution array technology assigned specific features to specific deleted intervals: short stature mapped to a narrow stretch at 13q31.3, microcephaly to 13q33.3–q34, cleft lip or palate to 13q31.3–q33.1, Dandy-Walker malformation to 13q32.2–q33.1, absent or small thumbs to two separate intervals, and small or absent eyes to deletions extending from 13q31.3 to the end of the chromosome.4PubMed. Phenotype and 244k array-CGH characterization of chromosome 13q deletions: an update of the phenotypic map of 13q21.1-qter This is not just academic bookkeeping. When a prenatal or postnatal test identifies a 13q deletion, the breakpoints tell the clinical team roughly what to expect and which specialists to involve.
What Causes Chromosome 13 Deletions
Most partial 13q deletions arise spontaneously (de novo) during the formation of egg or sperm cells, or very early in embryonic cell division. They are not typically inherited from a parent who carries the same deletion. Several mechanisms can produce the break.
Nondisjunction, where chromosomes fail to separate properly during cell division, is the best-studied route to chromosome 13 abnormalities. Research on trisomy 13 (the gain of a chromosome 13, rather than a loss) has shown that errors during egg-cell division are the most common source, and that advancing maternal age raises the risk.5PubMed Central. Maternal age and the risk of fetal aneuploidy: A nationwide cohort study of more than 500 000 singleton pregnancies in Denmark from 2008 to 2017 A dedicated study of chromosome 13 nondisjunction found some evidence for elevated maternal age when the error occurred during the mother’s egg development, and interestingly found that both maternal and paternal ages were elevated when the error originated in the father’s sperm, a pattern different from what is seen with chromosome 21.6Human Molecular Genetics. Non-disjunction of chromosome 13
One reason egg cells become more error-prone with age involves cohesin proteins, molecular “glue” that holds chromosome pairs together until they are ready to separate. Using fruit flies as a model, researchers demonstrated that when the cohesin protein SMC1 is reduced, aged oocytes show a significant increase in chromosome missegregation, and recombinant chromosomes that were supposed to stay together fall apart prematurely.7PubMed Central. Aging predisposes oocytes to meiotic nondisjunction when the cohesin subunit SMC1 is reduced While that work focused on a model organism and the gain-of-chromosome scenario, the same cohesin-degradation process can also lead to chromosome loss.
A different route to partial monosomy 13 involves Robertsonian translocations, where the long arms of two different chromosomes fuse. The most common of these affecting chromosome 13 is rob(13;14), a fusion of chromosomes 13 and 14. Carriers of this translocation are healthy but produce a mixture of balanced and unbalanced eggs or sperm. Preimplantation genetic testing data show that female carriers of rob(13;14) produce embryos with monosomy 13 or 14 at a rate of about 56%, compared with roughly 35% for male carriers.8European Journal of Human Genetics. Chromosome segregation of human nonhomologous Robertsonian translocations: insights from preimplantation genetic testing Most of these monosomic embryos fail to implant or miscarry, but the translocation is worth knowing about because it can recur in a family’s pregnancies.
The Critical Role of the 13q32 Band
Not all 13q deletions carry the same weight. Research consistently points to the 13q32 band as a pivotal region. A molecular study defining a critical deletion region within 13q32 found that all severely affected patients in the cohort had deletions overlapping this stretch, estimated at roughly one million base pairs in size, while mildly affected patients had deletions that included only part of it.9PubMed Central. The 13q- syndrome: the molecular definition of a critical deletion region in band 13q32 A later systematic molecular characterization of 14 patients with de novo 13q deletions confirmed that those lacking the 13q32 band were the most seriously affected and narrowed the interval associated with Dandy-Walker malformation to 13q32.2–q33.2, a zone containing the ZIC2 and ZIC5 genes.10Journal of Medical Genetics. 13q Deletion and central nervous system anomalies: further insights from karyotype–phenotype analyses of 14 patients
Clinically, this means that a child with a small interstitial deletion in the proximal part of 13q might have mild intellectual disability and few structural birth defects, while a child missing 13q32 and beyond may face severe brain malformations, limb anomalies, and organ involvement. Genetic counselors use the breakpoint data from chromosome testing to estimate where on this severity spectrum a given deletion falls.
Brain and Nervous System Involvement
Central nervous system malformations are among the most consequential features of 13q deletion syndrome, and they concentrate in deletions that include the 13q32 region. Holoprosencephaly, a condition in which the brain’s two hemispheres fail to separate properly, has been described in multiple fetuses with 13q deletions. A series of five cases showed a distinctive clover-shaped form of holoprosencephaly in second- and third-trimester fetuses with 13q deletions, and the researchers linked it to loss of the ZIC2 gene located at 13q32.11PubMed. Unusual variant of holoprosencephaly in monosomy 13q The genetics of holoprosencephaly in chromosome 13 abnormalities are not entirely simple, though. An analysis of both duplications and deletions involving chromosome 13 concluded that the brain malformation cannot be explained by the loss of a single chromosomal band, suggesting that multiple genes or regulatory elements interact.12PubMed. Occurrence of holoprosencephaly in chromosome 13 disorders cannot be explained by duplication/deficiency of a single locus
Other brain findings in 13q deletion syndrome include Dandy-Walker malformation (a structural abnormality of the cerebellum and nearby fluid spaces), absence of the corpus callosum (the bundle connecting the two brain hemispheres), and neural tube defects such as meningocele or encephalocele. The mapping work described earlier assigned these features to overlapping but not identical intervals within 13q32–q33, with dose-sensitive genes proximal to q33.2 implicated in neural tube defects specifically.10Journal of Medical Genetics. 13q Deletion and central nervous system anomalies: further insights from karyotype–phenotype analyses of 14 patients For families, the practical implication is that prenatal imaging of the brain becomes especially important once a 13q deletion is detected.
Heart Defects and Limb Anomalies
Congenital heart defects appear in a meaningful fraction of individuals with 13q deletions, though the responsible genomic intervals differ from those driving brain malformations. A report of tetralogy of Fallot in a woman with a deletion of 13q13.1–q13.2 prompted a literature review that found several other heart defects associated with overlapping proximal deletions, suggesting that this region harbors genes important to heart development.13PubMed Central. 13q13.1-q13.2 deletion in tetralogy of Fallot: clinical report and a literature review Separately, a child with a more distal deletion at 13q33.1–q34 also presented with congenital heart defects alongside facial anomalies and developmental delay, pointing to a second cardiac-relevant region further out on the chromosome arm.14PubMed. Congenital heart defect and mental retardation in a patient with a 13q33.1-34 deletion In other words, there may be at least two distinct stretches of 13q whose loss can disrupt heart formation.
Limb anomalies, particularly absent or underdeveloped thumbs and upper-limb differences, are another recognizable part of the syndrome. The gene GPC5, located in the 13q32 band, is expressed in the tissue that forms the developing limb bud, and its deletion has been implicated in upper-limb abnormalities seen in 13q deletion patients.15PubMed. Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress This overlap with the 13q32 critical region means that limb anomalies often appear alongside the more severe brain findings rather than in isolation.
Retinoblastoma Risk
One of the most actionable clinical concerns in 13q deletion syndrome is the risk of retinoblastoma, a childhood eye cancer. The RB1 tumor-suppressor gene sits at chromosome band 13q14.2, and patients whose deletion spans this region lose one of their two copies of RB1 in every cell. Under the two-hit model of cancer, these children already carry the “first hit” from birth, meaning a single additional mutation in the remaining RB1 copy in any retinal cell can trigger tumor formation.16PubMed Central. Retinoblastoma and mosaic 13q deletion: a case report Because of this, children with deletions encompassing 13q14.2 receive regular eye exams starting in infancy, often under anesthesia, to catch tumors when they are small and treatable.
Treatment of retinoblastoma in 13q deletion patients can be complicated by the fact that these children sometimes have lower baseline blood counts or are more sensitive to chemotherapy. A study at a major cancer center found that among 13q deletion patients treated with intra-arterial chemotherapy delivered directly to the eye, about 80% experienced at least one episode of severe blood-count drops, with neutropenia being the most common. Despite this, the two-year eye-survival estimate for eyes treated with targeted chemotherapy was 83%, showing that aggressive treatment remains worthwhile even in this genetically complex group.17Pediatric Blood & Cancer. Retinoblastoma Management in 13q Deletion Syndrome Patients Using Super-Selective Chemotherapies and Other Cancer-Directed Interventions Families whose child has a 13q deletion that includes the RB1 region should expect close oncology follow-up for the first several years of life.
Prenatal Screening and Its Limits
Noninvasive prenatal testing (NIPT), which analyzes fetal DNA fragments circulating in the mother’s blood, can flag a possible monosomy 13 during pregnancy. However, the accuracy for monosomy 13 is considerably lower than for better-known conditions like trisomy 21. In a Chinese cohort, NIPT identified 13 pregnancies as high-risk for monosomy 13, but among the 11 that underwent confirmatory invasive testing, only one was confirmed, giving a positive predictive value of about 9%.18PubMed. Results of screening and prenatal diagnosis for 71 fetuses with high risk for trisomy/monosomy 13 syndrome by non-invasive prenatal screening That means roughly nine out of ten positive NIPT results for monosomy 13 turn out to be false alarms.
A broader study of NIPT results for rare aneuploidies found a similar pattern: among cases with fetal or neonatal chromosome results available, 70% had normal chromosomes, and in some of the discordant cases the abnormal NIPT signal came from the mother rather than the fetus, including a handful linked to undiagnosed maternal cancers.19PubMed Central. Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling This is why professional guidelines emphasize that NIPT is a screening tool, not a diagnosis. A high-risk NIPT result for monosomy 13 should always be followed by amniocentesis or chorionic villus sampling, along with detailed ultrasound, before any clinical decisions are made. The same NIPT study noted that combining ultrasound findings with the screening result improved predictive accuracy, a practical point for families weighing next steps.
Confirming the Diagnosis After Birth
When a 13q deletion is suspected after birth, whether because of physical features, an abnormal prenatal screen, or an incidental finding, the standard first step is a karyotype from a blood sample. Standard chromosome banding can detect large deletions, but smaller or more complex rearrangements sometimes need additional tools. Fluorescence in situ hybridization (FISH) uses labeled DNA probes to check for specific missing regions, which is especially useful when the deletion is subtle or when the clinician wants to confirm whether a particular gene like RB1 is lost. Chromosomal microarray analysis (array CGH) has become the gold standard for pinning down the exact breakpoints and size of a deletion at high resolution.3Fetal Diagnosis and Therapy. Prenatal detection of a subtle unbalanced chromosome rearrangement by karyotyping, FISH and array comparative genomic hybridization
In at least some cases, what initially looks like a straightforward 13q deletion turns out to be part of a more complex rearrangement. One documented case was first reported as a simple chromosome 13 deletion based on banding, but array CGH revealed that the fetus actually had a gain of material from chromosome 2 in addition to the 13q loss, the result of an unbalanced translocation inherited from the father’s balanced rearrangement. This kind of finding changes the recurrence risk for future pregnancies and underscores why high-resolution testing matters, not just for the child but for the family’s reproductive planning.
Living with 13q Deletion Syndrome
For children with smaller deletions that spare the critical 13q32 region, the outlook can be fairly encouraging. Many have mild to moderate intellectual disability, may need speech and occupational therapy, and can attend school with support. Growth tends to be below average but not drastically so. For those with larger deletions extending through 13q32 and beyond, the medical picture is more complex, often involving surgical correction of heart defects or cleft palate, management of seizures, vision interventions, and intensive early-intervention services.
Because 13q deletion syndrome is rare, there is no single treatment protocol. Care is coordinated across specialties: genetics for the diagnosis and family counseling, cardiology for heart defects, ophthalmology and oncology for retinoblastoma surveillance, neurology for brain malformations and seizures, and orthopedics for limb differences. Parents often find that the most practically useful piece of information is the precise genomic coordinates of their child’s deletion, because those coordinates predict which systems are most likely to need monitoring. As microarray testing has become routine, families receive this information earlier and more reliably than they did a generation ago, which in turn lets clinical teams assemble the right surveillance plan from the start.
Mosaicism and Atypical Presentations
Not every individual with a 13q deletion carries it in every cell. In mosaic cases, some cells have the normal two copies of chromosome 13 while others carry the deletion. Mosaicism can soften the clinical picture considerably, because the normal cells partially compensate for the deleted ones. One case report described mosaic 13q deletion in a patient who developed retinoblastoma but had milder systemic features than would be expected for the size of the deletion.16PubMed Central. Retinoblastoma and mosaic 13q deletion: a case report Mosaicism also complicates diagnosis: a standard blood karyotype might miss a deletion present at low levels, or a prenatal test might detect it in placental cells but not in the fetus itself. When clinical features suggest a chromosome problem but initial testing is normal, mosaicism is one of the explanations worth investigating with additional tissue sampling or deeper analysis.
Ring chromosome 13 is another atypical presentation. When both ends of chromosome 13 break and the remaining piece forms a circle, some genetic material from the tips is lost. Ring chromosomes also tend to be unstable during cell division, frequently being lost from daughter cells, which creates a secondary monosomy 13 mosaicism. The combination of terminal deletion and ongoing chromosome instability means that ring 13 patients can present with a blend of features from both the deleted region and the consequences of monosomic cell lines. Their clinical course is harder to predict from the initial genetic test alone, and follow-up testing over time may be warranted to track whether the ring is being lost from blood cells at an accelerating rate.